Yun-Fei Wang Selected Research

huxin

1/2014	Efficacy and safety of Huxin formula in patients after CABG: a multicenter, double-blind, randomized clinical trial.
1/2014	A multicentre randomized clinical trial on efficacy and safety of huxin formula in patients undergoing percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Fei Wang Research Topics

Disease

6	Neoplasms (Cancer) 03/2022 - 05/2013
4	Glioma (Gliomas) 01/2019 - 05/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 01/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2022
1	Lymphatic Metastasis 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Papillomavirus Infections 01/2020
1	Pseudomyxoma Peritonei 11/2019
1	Spinal Cord Diseases 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Ossification of Posterior Longitudinal Ligament 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Hyperthermia 03/2018
1	Ebola Hemorrhagic Fever 04/2017
1	Infections 04/2017
1	Myocardial Infarction 01/2014
1	Angina Pectoris 01/2014
1	Unstable Angina 01/2014
1	Coronary Disease (Coronary Heart Disease) 01/2014
1	Gangrene 10/2008
1	Ulcer 10/2008
1	Wounds and Injuries (Trauma) 10/2008
1	Carbuncle 10/2008

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2019
2	Long Noncoding RNAIBA 01/2019 - 01/2019
2	epidermal growth factor receptor VIIIIBA 10/2017 - 05/2013
2	CytokinesIBA 04/2017 - 05/2013
2	huxinIBA 01/2014 - 01/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2022
1	AgarIBA 03/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	apatinibIBA 11/2019
1	Competitive Endogenous RNAIBA 01/2019
1	CateninsIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Pharmaceutical PreparationsIBA 03/2018
1	SolutionsIBA 03/2018
1	ChemokinesIBA 04/2017
1	A-factor (Streptomyces)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	AntigensIBA 05/2013
1	Chimeric Antigen ReceptorsIBA 05/2013
1	Therapeutic UsesIBA 10/2008
1	qingre huoxueIBA 10/2008

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2014 - 10/2008
2	Therapeutics 10/2008 - 10/2008
1	Hyperthermic Intraperitoneal Chemotherapy 11/2019
1	Laminoplasty 01/2019
1	Decompression 01/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2014
1	Percutaneous Coronary Intervention 01/2014
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2008
1	Surgical Amputation (Amputations) 10/2008